Drug Trial Radar · NCT06316297
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
800
Planned (sponsor's estimate)
Start
Apr 5, 2024
Primary completion
Nov 30, 2028
Study completion Nov 30, 2028
Sponsor
- Lead sponsor
- Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Mar 18, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to four dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a Core Study followed by an optional Long-Term Extension (LTE). The Core Study will consist of: * Two cohorts evaluating the 2-administration regimen (Cohorts A): Sentinel Cohort A and Main Cohort A. * Two cohorts evaluating the 3-administration regimen (Cohorts B): Sentinel Cohort B and Main Cohort B. Participants from Sentinel Cohorts A and B and from Main Cohort A will be invited to an additional 30-month follow up after completing their last planned Core Study visit to assess the long-term effects of the vaccine. Participants from Main Cohort B will be invited to another LTE study managed through a separate protocol.
Conditions
- Acne
Interventions
Acne mRNA vaccineBiological
Pharmaceutical form: Liquid suspension for injection Route of administration: intramuscular
PlaceboOther
Pharmaceutical form: Liquid solution for injection Route of administration: intramuscular
Primary outcomes
What the sponsor says the trial is designed to measure.
- Core Study - Sentinel Cohorts A and B: Number of participants with unsolicited systemic AEsTime frame: 30 minutes after each administration
- Core Study - Sentinel Cohorts A and B: Number of participants with solicited injection site and systemic reactionsTime frame: Up to 7 days after each administration
- Core Study - Sentinel Cohorts A and B: Number of participants with unsolicited AEsTime frame: Up to 28 days after each administration
- Core Study - Sentinel Cohorts A and B: Number of participants with MAAEsTime frame: Up to 6 months after each administration
- Core Study - Sentinel Cohorts A and B: Number of participants with SAEsTime frame: Up to 6 months after each administration
- Core Study - Sentinel Cohorts A and B: Number of participants with AESIsTime frame: Up to 6 months after each administration
- Core Study - Sentinel Cohorts A and B: Number of participants with out-of-range biological test results (including shift from baseline values)Time frame: Through 7 days after administration (Day 8)
- Core Study - Main Cohort A: Percentage change from baseline (Day 1) in the number of inflammatory acne lesions on faceTime frame: At 2 months post last administration
- Core Study - Main Cohort A: Percentage change from baseline (Day 1) in the number of non-inflammatory acne lesions on faceTime frame: At 2 months post last administration
- Core Study - Main Cohort B: Percentage change from baseline (Day 1) in the total number of acne lesions on face atTime frame: At 2 months post last administration
- Long-Term Extension - Sentinel Cohorts A, B and Main Cohort: Number of participants with SAEs and AESIsTime frame: Up to 38 or 40 months after first administration
Locations
94 sites in 4 countries. Site status is shown where the registry gives one.
Center for Dermatology and Plastic Surgery- Site Number : 8400111
Scottsdale, Arizona · Recruiting
Private Practice - Dr. Francisco Badar- Site Number : 8400067
Cerritos, California · Recruiting
Encino Research Center- Site Number : 8400033
Encino, California · Recruiting
Paradigm Clinical Research Centers- Site Number : 8400064
La Mesa, California · Recruiting
Sunwise Clinical Research- Site Number : 8400108
Lafayette, California · Recruiting
Chemidox Clinical Trials- Site Number : 8400075
Lancaster, California · Recruiting
Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400058
Los Angeles, California · Recruiting
LA Universal Research Center- Site Number : 8400059
Los Angeles, California · Recruiting
Alliance Clinical - West Hills- Site Number : 8400131
Los Angeles, California · Recruiting
Carbon Health - North Hollywood - NoHo West- Site Number : 8400076
North Hollywood, California · Recruiting
Northridge Clinical Trials - Northridge- Site Number : 8400053
Northridge, California · Recruiting
Profound Research - Dermatologist Medical Group of North County- Site Number : 8400099
Oceanside, California · Recruiting
Cura Clinical Research - Oxnard- Site Number : 8400062
Oxnard, California · Recruiting
Amicis Research Center, LLC- Site Number : 8400110
Palmdale, California · Recruiting
Empire Clinical Research - Pomona- Site Number : 8400055
Pomona, California · Recruiting
Peninsula Research Associates- Site Number : 8400102
Rolling Hills Estates, California · Recruiting
Artemis Institute for Clinical Research - San Diego - Washington Street- Site Number : 8400103
San Diego, California · Recruiting
California Research Foundation- Site Number : 8400095
San Diego, California · Recruiting
NorthBay Clinical Research- Site Number : 8400066
Santa Rosa, California · Recruiting
Encore Medical Research of Boynton Beach- Site Number : 8400116
Boynton Beach, Florida · Recruiting
Driven Research- Site Number : 8400135
Coral Gables, Florida · Recruiting
HealthMed Clinical Center- Site Number : 8400071
Coral Gables, Florida · Recruiting
Universal Medical Research - Coral Gables- Site Number : 8400081
Coral Gables, Florida · Recruiting
Genomics Medical Research- Site Number : 8400120
Cutler Bay, Florida · Recruiting
Direct Helpers Research Center- Site Number : 8400118
Hialeah, Florida · Recruiting
Zenith Clinical Research- Site Number : 8400127
Hollywood, Florida · Recruiting
Encore Medical Research - Hollywood- Site Number : 8400122
Hollywood, Florida · Recruiting
Universal Medical and Research Center- Site Number : 8400079
Homestead, Florida · Recruiting
Encore Research Group-Jacksonville Center for Clinical Research- Site Number : 8400006
Jacksonville, Florida · Recruiting
K2 Medical Research - The Villages - Northeast 138th Lane- Site Number : 8400063
Lady Lake, Florida · Recruiting
Dr. Manuel J Hernandez Clinical Research and Associates, Inc.- Site Number : 8400106
Miami, Florida · Recruiting
SouthCoast Research Center- Site Number : 8400114
Miami, Florida · Recruiting
Advanced Medical Research Institute - Miami- Site Number : 8400100
Miami, Florida · Recruiting
Health and Life Research Institute- Site Number : 8400070
Miami, Florida · Recruiting
WellQuest Clinical- Site Number : 8400082
Miami, Florida · Recruiting
Renstar Medical Research - Ocala - Northeast 1st Avenue- Site Number : 8400021
Ocala, Florida · Recruiting
Leading Edge Dermatology- Site Number : 8400077
Plantation, Florida · Recruiting
Nuline Clinical Trial Center- Site Number : 8400060
Pompano Beach, Florida · Recruiting
D&H Tamarac Research Center- Site Number : 8400121
Tamarac, Florida · Recruiting
TrueBlue Clinical Research- Site Number : 8400016
Tampa, Florida · Recruiting
Showing 40 of 94 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.